These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17125935)

  • 41. Experimental models and their use in studies of diabetic retinal microangiopathy.
    Bazan NG; Gordon WC; Marcheselli VL; Lukiw WJ; Duhault J; Koenig-Berard E; Linn DM; DeCoster MA; Mukherjee PK
    Therapie; 1997; 52(5):447-51. PubMed ID: 9501573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.
    Chetthakul T; Likitmaskul S; Plengvidhya N; Suwanwalaikorn S; Kosachunhanun N; Deerochanawong C; Krittiyawong S; Leelawatana R; Benjasuratwong Y; Bunnag P; Prathipanawatr T; Ngarmukos C; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S17-26. PubMed ID: 17715830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice.
    Steinle JJ; Kern TS; Thomas SA; McFadyen-Ketchum LS; Smith CP
    Exp Eye Res; 2009 Jun; 88(6):1014-9. PubMed ID: 19176214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
    Petrovic MG; Korosec P; Kosnik M; Hawlina M
    Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in biochemical mechanisms of diabetic retinopathy.
    Giusti C; Gargiulo P
    Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MHC class II antigen expression by ocular cells in proliferative diabetic retinopathy.
    Baudouin C; Fredj-Reygrobellet D; Brignole F; Lapalus P; Gastaud P
    Fundam Clin Pharmacol; 1993; 7(9):523-30. PubMed ID: 8314197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?
    Ezquer F; Ezquer M; Arango-Rodriguez M; Conget P
    Acta Ophthalmol; 2014 Mar; 92(2):e86-95. PubMed ID: 23773776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy.
    Yang R; Liu H; Williams I; Chaqour B
    Ann N Y Acad Sci; 2007 Apr; 1103():196-201. PubMed ID: 17332085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy.
    Yamaji Y; Yoshida S; Ishikawa K; Sengoku A; Sato K; Yoshida A; Kuwahara R; Ohuchida K; Oki E; Enaida H; Fujisawa K; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3151-7. PubMed ID: 18316703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Endothelial dysfunction of central retinal vessels: a prognostic parameter for diabetic retinopathy?].
    Dawczynski J; Mandecka A; Blum M; Müller UA; Ach T; Strobel J
    Klin Monbl Augenheilkd; 2007 Nov; 224(11):827-31. PubMed ID: 18034395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
    Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
    Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Contents of T-lymphocytes and expression of intercellular adhesion molecule ICAM-1 in the retina and choroid in diabetic retinopathy].
    Zhaboedov GD; Skripnik RL; Sidorova MV
    Vestn Oftalmol; 2001; 117(5):41-3. PubMed ID: 11765468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy.
    Ejaz S; Chekarova I; Ejaz A; Sohail A; Lim CW
    Diabetes Obes Metab; 2008 Jan; 10(1):53-63. PubMed ID: 17941874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunopathologic study of retinal detachment with vitreo-retinal proliferation].
    Baudouin C; Fredj-Reygrobellet D; Jambou D; Righini M; Gastaud P
    Ophtalmologie; 1989; 3(1):22-5. PubMed ID: 2518136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
    Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are phospholipid-binding antibodies implicated in the pathogenesis of diabetic microangiopathy?
    Giusti C
    Med Hypotheses; 2004; 63(2):235-8. PubMed ID: 15236781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.